NCT02201511 - A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Healthy

Interventions

DRUG

3 mg PF-06412562 MR tablets_Fasted

A single modified release tablet with 3 mg PF-06412562 administered after an overnight fast

DRUG

2 x 15 mg PF-06412562 MR tablets_Fasted

Two 15 mg PF-06412562 modified release tablets administered after an overnight fast

DRUG

2 x 15 mg PF-06412562 MR tablets_Fed

Two 15 mg PF-06412562 modified release tablets administered after a high fat breakfast

DRUG

10 mg PF-06412562 IR tablets

a single immediate release tablet of 10 mg PF-06412562 after an overnight fast

Trial Locations (1)

Pfizer Clinical Research Unit, Brussels